We are extremely excited to announce this year's newly funded projects in the Columbia Biomedical Technology Accelerator portfolio.
Funds are awarded to perform a "killer experiment", that is, an experiment that will substantially remove risk and leave no doubt that the product will be an improvement over the status quo.
CONGRATULATIONS TO THE FOLLOWING TEAMS!
Cuffless, non-invasive, and self-calibrating device for accurate and ambulatory measurements of blood pressure. Samuel K. Sia, PhD; Daichi Shimbo, MD
Rapid, point-of-care, low-cost aneuploidy screening using a handheld nanopore-based DNA sequencer. Zev Williams, MD, PhD; Shan Wei, PhD
Biomimetic lung sealant to rapidly heal pulmonary air leaks, decrease recovery time, and reduce healthcare costs. Gordana Vunjak-Novakovic, PhD; Matthew Bacchetta, MD, MBA
A novel CRISPR/Cas 9 Based Mutation Correction Method for Hemoglobinopathies. Suleyman Ucuncuoglu, PhD; Wendy Chung, MD, PhD **Co-funded with TRx, initiative of CTSA from NIH and Irving Institute
Drug Based Modulation of Endogenous Fibrocartilage Stem Cells for TMJ Regeneration. Mildred C. Embree, MS, DMD, PhD; Mo Chen, PhD, MBA **Co-funded with TRx, initiative of CTSA from NIH and Irving Institute